Advertisement

Topics

Myriad Genetics, Inc. Company Profile

07:05 EST 20th November 2017 | BioPortfolio

Myriad Genetics, Inc. is a biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products. Myriad's news and other information are available on the Company's Web site at www.myriad.com. BRACAnalysis(R) is a registered trademark of Myriad Genetics, Inc. in the U.S. and other countries.


News Articles [531 Associated News Articles listed on BioPortfolio]

$0.21 Earnings Per Share Expected for Myriad Genetics, Inc. (MYGN) This Quarter

Wall Street brokerages forecast that Myriad Genetics, Inc. will post earnings of $0.21 per share for the current quarter, Zacks reports. Five analysts have made estimates for Myriad Genetics' earn...

Myriad Genetics Inc. Q4 Earnings Decline 21%

WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) released a profit for fourth quarter that dropped from last year.The company said its earnings fell to $20.8 million, or $0.30 per share. This wa...

Myriad Genetics, Inc. (MYGN) Sets New 12-Month High at $33.08

Myriad Genetics, Inc. 's share price hit a new 52-week high during trading on Wednesday . The stock traded as high as $33.08 and last traded at $33.04, with a volume of 1,166,494 shares changing h...

Myriad Genetics, Inc. (MYGN) Releases Q2 Earnings Guidance

Myriad Genetics, Inc. updated its second quarter earnings guidance on Tuesday. The company provided earnings per share guidance of $0.22-0.24 for the period, compared to the Thomson Reuters consensus ...

Reviewing Myriad Genetics

Myriad Genetics and Cepheid are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, divide...

Palmetto, Anthem to cover use of Myriad's breast cancer recurrence test

Myriad Genetics obtained positive coverage decisions from Anthem and Medicare contractor Palmetto GBA for its EndoPredict bre -More- 

Myriad Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 13062017] Prices from USD $350

Myriad Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Myriad Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment...

Myriad Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 18102017] Prices from USD $350

Myriad Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Myriad Genetics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment...

Drugs and Medications [0 Results]

None

PubMed Articles [578 Associated PubMed Articles listed on BioPortfolio]

Skull Base Neuroendoscopic Training Model Using a Fibrous Injectable Tumor Polymer and the Nico Myriad.

The Myriad is an innovative, high precision tool for tumor resection, designed to work within narrow endoscopic corridors. Due to its application in technically demanding situations, the learning curv...

The Clinic Is My Laboratory: Life as a Clinical Geneticist.

Clinical genetics is the application of advances in genetics and medicine to real human families. It involves diagnosis, care, and counseling concerning options available to affected individuals and t...

Introduction to behavioral phenotypes in medical genetics.

25 more years.

This month, to celebrate a quarter century of excellence in genetics, we are highlighting selections from the past work we have published. We will then publish a number of forward-looking Perspectives...

Ocular genetics in Taiwan.

Ocular genetics is an emerging specialty which has accompanied the advancement of modern genetic technology. This review is to understand the current status of practice in ocular genetics in Taiwan.

Clinical Trials [300 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

Cultural Congruence in International Genetics Research

This study will explore how cultural differences influence genetics research in developing countries. Human genetics research is becoming more common in developing countries. However, when...

Companies [61 Associated Companies listed on BioPortfolio]

Myriad Genetics, Inc.

Myriad Genetics, Inc. is a biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products. Myriad's news and other information are available on t...

Myriad House

PR Week ranks Myriad as a UK top 150 PR agency and as number one in Cambridgeshire and across the East of England region. One of the country’s leading healthcare agencies, and among the largest...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

More Information about "Myriad Genetics, Inc." on BioPortfolio

We have published hundreds of Myriad Genetics, Inc. news stories on BioPortfolio along with dozens of Myriad Genetics, Inc. Clinical Trials and PubMed Articles about Myriad Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Myriad Genetics, Inc. Companies in our database. You can also find out about relevant Myriad Genetics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record